Yemaachi Biotechnology
New accelerator entry · 2021-08-01 · the record
In their words
Yemaachi Biotech is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa, which is the most genetically diverse population on the planet. We then use this data to either optimize existing diagnostic tests, or help other companies discover new ones. With our research activities based in Africa, we are able to leverage access to the most genetically diverse population on the planet to build a first-of-its-kind clinical and molecular knowledgebase on cancer among African people.
What the record says
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Yemaachi Biotechnology
- Source Check — verify what Yemaachi Biotechnology states, against the registers that hold it.
- INVEST — size up this company on the figures its record states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Yemaachi Biotechnology for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Yemaachi BiotechnologyYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Yemaachi Biotechnology: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.